Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julian E. Liebenberg"'
Publikováno v:
Parasites & Vectors, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Background The parthenogenic reproductive ability of Haemaphysalis longicornis, facilitating quick life cycle completion and rapid geographic spread and its pathogen vector potential make infestations a risk to human and canine health. Two 9
Externí odkaz:
https://doaj.org/article/9b5d2ed155304bd3b0fae10dc510fea1
Publikováno v:
Parasites & Vectors, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Background The invasive tick species, Haemaphysalis longicornis, is becoming established in the USA, presenting a growing threat to dogs and cats. Two 90-day studies were initiated, the same protocol in each, to confirm the efficacy of a sin
Externí odkaz:
https://doaj.org/article/de38077b92a1464381a1a826b355ad45
Publikováno v:
Parasites & Vectors, Vol 16, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/b2367b2a5cf9469e92dc88c87fc58bbe
Publikováno v:
Parasites & Vectors, Vol 12, Iss 1, Pp 1-6 (2019)
Abstract Background The southern African yellow dog tick, Haemaphysalis elliptica, occurs in eastern and southern Africa and adults infest domestic and wild carnivores. This tick species is also a vector of the highly virulent Babesia rossi pathogen,
Externí odkaz:
https://doaj.org/article/d742124ff9e64152a88f5c4b73686945
Publikováno v:
Parasites & Vectors, Vol 10, Iss 1, Pp 1-7 (2017)
Abstract Background The oral systemic efficacy of lotilaner (Credelio™, Elanco) was evaluated against Demodex spp. in naturally infested dogs with generalized demodicosis. Methods In this study, 10 dogs with clinical signs of generalized demodicosi
Externí odkaz:
https://doaj.org/article/dc120e55c84c4e619c839e968ad4d5d2
Autor:
Josephus J Fourie, Julian E Liebenberg, Ivan G Horak, Janina Taenzler, Anja R Heckeroth, Regis Frénais
Publikováno v:
Parasites & Vectors, Vol 8, Iss 1, Pp 1-7 (2015)
Abstract Background This laboratory study compared the efficacy of Bravecto™ (fluralaner), formulated as a chewable tablet, with the efficacy of Advocate® (imidacloprid/moxidectin), formulated for topical administration, against naturally acquired
Externí odkaz:
https://doaj.org/article/2a938704351b4971bb2c7be86d7f4b72